comparemela.com

Latest Breaking News On - Biopharma culture - Page 4 : comparemela.com

US lawmakers urge Biden administration to impose sanctions on China s Wuxi AppTech

TILT Biotherapeutics awarded $2 million grant for ovarian cancer research

TILT Biotherapeutics, a clinical-stage biotech company developing cancer immunotherapies, has received a $2 million grant from the U.S. Department of Defense (DOD) for a three-year project to treat ovarian cancer using its TILT-123 asset.

New appointments in the pharma industry so far in 2024

Outsourcing Pharma and BioPharma Reporter breaks down the key people on the move in the pharma industry. Enhanc3D Genomics, Cytomos and Cellular Origins are among the companies welcoming new faces to top jobs.

Beyond chemotherapy: Navigating the promise and perils of CAR-T therapy in pediatric cancer

Upon hearing the phrase ‘cancer treatment’, the first word that can typically spring to mind is chemotherapy – a primary therapy which uses powerful chemicals to destroy rapidly growing cancer cells in the body.

TrakCel launches consultancy services to share industry expertise

TrakCel, a provider of cellular orchestration systems to the cell and gene therapy (CGT) industry, has launched its own consultancy services to share its process development knowledge with the broader community of CGT developers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.